期刊文献+

右美托咪定对重症监护室患者镇静效果评价 被引量:2

Evaluation of sedation effect by dexmedetomidine for patients in intensive care unit
下载PDF
导出
摘要 目的探讨右美托咪定对重症监护室患者的镇静效果。方法回顾性分析53例接受镇静治疗重症监护室患者的临床资料,所有患者均给予右美托咪定,观察患者的镇静效果及用药后不良反应发生情况。结果本组53例患者在使用右美托咪定治疗后均取得了满意的镇静效果,Ramsay镇静分级维持在2~4级。平均唤醒时间(0.24±0.02)h,平均机械通气时间(4.86±1.42)h,用药过程中不良反应发生率为9.4%。结论右美托咪定具有较好的镇静作用,适用于重症监护室患者的镇静治疗。 ObjectiveTo investigate sedation effect by dexmedetomidine for patients in intensive care unit.MethodsA retrospective analysis was made on clinical data of 53 patients receiving sedation treatment in intensive care unit. All patients received dexmedetomidine, and their sedation effects and adverse reactions were observed.ResultsAll 53 cases had satisfactory sedation effect after taking dexmedetomidine for treatment, with Ramsay score in 2~4 grades. Their average awake time was (0.24±0.02) h, average mechanical ventilation time was (4.86±1.42) h, and incidence of adverse reactions during medication was 9.4%.Conclusion Dexmedetomidine shows remarkable sedation effect, and it is suitable for patients in intensive care unit.
作者 何琼珍
出处 《中国实用医药》 2016年第13期32-33,共2页 China Practical Medicine
关键词 重症监护室 右美托咪定 镇静 效果 Intensive care unit Dexmedetomidine Sedation Effect
  • 相关文献

参考文献7

二级参考文献46

  • 1Martin J, Franck M, Fischer M, et al. Sedation and analgesia in Ger- man intensive care units: how is it done in reality? Results of a patient -based survey of analgesia and sedation [ J ]. Intensive Care Med, 2006,32(8) :1137 - 1142.
  • 2Pandharipande PP, Pun BT, Herr DL, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechani- cally ventilatedpatients: the MENDS randomized controlled trial [ J]. JAMA, 2007,298 ( 22 ) :2644 - 2653.
  • 3Gerlach AT, Dasta JF. Dexmedetomidine : an updated review [ J ]. Ann Pharmacother, 2007,41 (2) :245 - 252.
  • 4赵逵.MELD评分与Child-Pugh评分与肝功能分级[A].2006年消化系病学术年会暨胰腺疾病专题讲座论文汇编[C],2006.
  • 5Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond Agitation - Se- dation Scale: validity and reliability in adult intensive care unit patients [ J]. Am J Respir Crit Care Med, 2002,166 (10) : 1338 - 1344.
  • 6Riker RR, Shehabi Y, Bokeseh PM, et al. Dexmedetomidine vs midazo- lain for sedation of critically ill patients : a randomized trial[ J]. JAMA, 2009,301 (5) :489 -499.
  • 7Maldonado JR, Wysong A, van der Starre PJ, et al. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery [ J ]. Psychosomatics, 2009,50 (3) :206 - 217.
  • 8kBerkowitz DE, Price DT, Bello EA, et al. Localization of messenger RNA tbr three distinct alpha 2-adrenergic receptor subtypes in human tissues: evidence for species heterogeneity and implications for human pharmacology[J]. Anesthesiology, 1994, 81: 1235-1244.
  • 9Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guide- lines for the sustained use of sedatives and analgesics in the criti-cally ill adult[J]. Crit Care Med, 2002, 30: 119-141.
  • 10Riker RR, Fraser GL. Altering intensive care sedation para- digms to improve patient outcomes[J]. Anesthesiol Clin, 2011, 29: 663-674.

共引文献31

同被引文献16

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部